Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) — Tangible Net Worth Ratio
Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) has a Tangible Net Worth Ratio of 94.6% as of March 2026. This metric is calculated by deducting intangible assets (CN¥79.42 Million) from net assets (CN¥1.47 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) equity growth momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Xinxiang Tuoxin Pharmaceutical Co.Ltd. Tangible Net Worth Ratio (2019–2025)
This chart shows how Xinxiang Tuoxin Pharmaceutical Co.Ltd.'s Tangible Net Worth Ratio has changed across 7 annual periods from 2019 to 2025. As of March 2026, the ratio stands at 94.6%, reflecting net assets of CN¥1.47 Billion with intangible assets of CN¥79.42 Million CNY. For live market cap and overall valuation, see Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) market capitalisation.
Annual Tangible Net Worth Ratio for Xinxiang Tuoxin Pharmaceutical Co.Ltd. (2019–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Xinxiang Tuoxin Pharmaceutical Co.Ltd. from 2019 to 2025, covering 7 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore reinvestment intensity of Xinxiang Tuoxin Pharmaceutical Co.Ltd. to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 94.6% | CN¥1.48 Billion | CN¥80.12 Million | CN¥1.67 Billion | ▼ -0.1 pp |
| 2024 | 94.7% | CN¥1.55 Billion | CN¥81.83 Million | CN¥1.76 Billion | ▼ 0.0 pp |
| 2023 | 94.8% | CN¥1.60 Billion | CN¥84.04 Million | CN¥1.84 Billion | ▲ +0.9 pp |
| 2022 | 93.9% | CN¥1.38 Billion | CN¥84.26 Million | CN¥1.84 Billion | ▲ +1.6 pp |
| 2021 | 92.3% | CN¥1.10 Billion | CN¥84.56 Million | CN¥1.39 Billion | ▲ +6.8 pp |
| 2020 | 85.5% | CN¥490.87 Million | CN¥71.02 Million | CN¥946.48 Million | ▲ +4.6 pp |
| 2019 | 80.9% | CN¥383.11 Million | CN¥73.04 Million | CN¥739.85 Million | — |